Editorial of Special Column “Research on Emerging COVID-19 (Target, Mechanism, and Therapeutics)”

• Hai-Bin Luo,
• Shilin Chen,
• Peiqing Liu

Affiliations

Hai-Bin Luo

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China

Shilin Chen

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China

Peiqing Liu

Laboratory of Pharmacology & Toxicology and New Drug R&D Center, School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China